Hims & Hers (HIMS) Faces FTC Lawsuit Over Health Data Sharing And Deceptive Billing Practices
The FTC, with Utah and California, sued telehealth provider Hims & Hers (HIMS), alleging it shared consumers’ sensitive health data with ad platforms including Meta, Snap, Microsoft, Pinterest, Reddit, and X. Regulators also claim deceptive billing and cancellation practices, including unwanted auto-renewing medication subscriptions. Hims & Hers disclosed a $15 million probable-loss accrual in May and denies wrongdoing.
How this was made
The 30-second read
Why it matters
A newly filed federal lawsuit with state co-plaintiffs adds formal litigation risk and may increase expected costs beyond the previously disclosed accrual, while also pressuring privacy and subscription practices.
Market read
This is a fresh, concrete regulatory escalation with specific allegations about ad-tech health-data sharing and subscription consent and cancellation, likely to drive repricing of legal and compliance risk.
What to watch
The article notes a prior Novo Nordisk GLP-1 compounded-medication dispute resolution; investors may already be focused on GLP-1 risk, so the incremental impact depends on whether regulators target core revenue streams beyond billing and tracking.
Background
The FTC communicated findings from a 2023 probe in April, settlement discussions began, and Hims & Hers disclosed a $15 million probable-loss accrual in May.
Ticker impact
FTC and Utah/California sued Hims & Hers for allegedly sharing sensitive health data with ad platforms and deceptive subscription billing.
Downward bias over days to weeks as investors price higher legal overhang and possible operational constraints.
The article describes a newly filed FTC lawsuit with state co-plaintiffs, specific allegations about data sharing via Meta/Snap/Microsoft/Pinterest/Reddit/X, and deceptive billing and cancellation practices affecting hundreds of thousands.
Market effects
Telehealth DTC peers face heightened scrutiny on health-data ad targeting, pixel tracking, and subscription consent and cancellation UX.
US regulatory pressure intensifies, with California and Utah expanding state-law exposure alongside the FTC.
US enforcement actions can spill over into broader privacy and consumer-protection expectations for digital health platforms.
Counterpoint
Hims & Hers may argue it followed industry standards and provided evidence to the FTC, so outcomes could be limited if claims are narrowed or settled.
Key entities
- companyHims & Hers
Direct-to-consumer telehealth platform accused of health-data sharing with ad platforms and deceptive billing/cancellation practices.
- regulatorFederal Trade Commission (FTC)
Filed suit alleging violations of the FTC Act and the Restore Online Shoppers’ Confidence Act.
- companyMeta
Named as a third-party advertising platform allegedly receiving health information via trackers.
- companySnap
Named as a third-party advertising platform allegedly receiving health information via trackers.
- companyMicrosoft
Named as a third-party advertising platform allegedly receiving health information via trackers.
